Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UC-MSC transplantation for pediatric septic shock
ChiCTR1800017366Phase 2Recruiting
- Sponsor
- Army Specialized Medical Center
- Start
- Aug 2018
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label trial of human umbilical cord derived mesenchymal stem cells in septic shock (4 arms), sponsored by Army Specialized Medical Center. Primary endpoint: Pediatric Index of Mortality. Started Aug 2018; status: recruiting.
02
Drugs
human umbilical cord derived mesenchymal stem cells
03
Conditions
septic shock
Beyond the preview
Go deeper on ChiCTR1800017366.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800017366.